We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Name | Symbol | Market | Type |
---|---|---|---|
Global X China Biotech Innovations ETF | NASDAQ:CHB | NASDAQ | Exchange Traded Fund |
Price Change | % Change | Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 6.64 | 2.67 | 10.66 | 0 | 00:00:00 |
RNS Number:9141N Cater Allen International Limited 24 July 2003 Date of Disclosure 24/07/03 DISCLOSURE UNDER RULES 8.1(a), 8.1(b)(i) and 8.3 OF THE CITY CODE ON TAKEOVERS AND MERGERS Date of dealing 22/07/03 Dealing in CHUBB PLC (name of company) 1) Class of securities (eg ordinary shares) ORDINARY SHARES 2) Amount bought Amount sold Price per unit 3,000,000 75.5P 3,000,000 75.5P 3,000,000 75.5P 3) Resultant total of the same class owned or controlled (and percentage of class) 11,000,000* (1.32%) 4) Party making disclosure CATER ALLEN INTERNATIONAL LIMITED 5) EITHER (a) Name of purchaser/vendor(Note 1)CATER ALLEN INTERNATIONAL LIMITED OR (b) if dealing for discretionary client(s), name of fund management organisation 6) Reason for disclosure (Note 2) (a) associate of (i) offeror (Note 3) NO (ii) offeree company NO Specify which category or categories of associate (1-8 overleaf) If category (8), explain (b) Rule 8.3 (ie disclosure because of ownership or control of 1% or more of the class of relevant securities dealt in) YES Signed, for and on behalf of the party named in (4) above N/A (Also print name of signatory) PHILIP HINDLEY Telephone and extension number 0207 7756 6169 *IN ADDITION, CATER ALLEN INTERNATIONAL IS PARTY TO CERTAIN TOTAL RETURN SWAPS AS DESCRIBED BELOW. Note 1. Specify owner, not nominee or vehicle company. If relevant, also identify controller of owner, eg where an owner normally acts on instructions of a controller Note 2. Disclosure might be made for more than one reason; if so, state all reasons. Note 3. Specify which offeror if there is more than one. Note 4. When an arrangement exists with any offeror, with the offeree company or which an associate of any offeror or of the offeree company in relation to relevant securities, details of such arrangement must be disclosed, as required by Note 6 on Rule 8 Note 5. It may be necessary, particularly when disclosing derivative transactions, to append a sheet to this disclosure form so that relevant information can be given. Note 6. In the case of an average price bargain, each underlying trade should be disclosed. For full details of disclosure requirements, see Rule 8 of the Code. If in doubt, contact the Panel on Takeovers and Mergers, Tel No: 020 7382 9026 Form 8 Enclosure Cater Allen International is the beneficial owner of 20,000,000 ordinary shares of Chubb Plc, all of which are held to hedge Total return Swaps (TRS') positions for clients. A Total Return Swap is a product used by clients to finance long positions. The client will sell their position to CAIL for which they will receive the current market price. The Client will then receive money if the price of the share sold increases above the sale price or pay money if it falls. In addition the client will pay an agreed rate of interest on the money received. The product can also be to finance short positions. CAIL will follow its normally policy in respect of such products, which is to vote the shares in accordance with the instructions of the counterparty for whom we are financing the positions. The following Total Return Swaps are executed: Date Underlying Reference CAIL Buy Maturity Product Executed number of Price or Sell Type shares Performance 17/06/03 20,000,000 75.5 SELL 19/12/03 TRS 20/06/03 9,000,000 75.5 BUY 19/12/02 TRS TOTAL 11,000,000 Signed, for and on behalf of the party named in (4) above (Also print name of signatory) PHILIP HINDLEY Telephone and extension number 0207 7756 6169 This information is provided by RNS The company news service from the London Stock Exchange END DCCPUUUAMUPWUBC
1 Year Global X China Biotech I... Chart |
1 Month Global X China Biotech I... Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions